In today’s market, there are numerous cell and tissue types that (a) cannot be cryopreserved or (b) can be cryopreserved, but lose viability during the freeze-thaw process. Cryopreservation is a critical platform technology for biomedical research and applications with promising global markets for CryoCrate’s media and associated devices. In 2015, CryoCrate received a National Institutes of Health Small Business Innovation Research (SBIR) award for its cryopreservation device development. In 2016, CryoCrate received a Fast-Track Award from the University of Missouri for cryopreservation media GMP production and a Coulter Partnership award for an innovative device for the cryopreservation of corneas.


The MISSION of CryoCrate is to revolutionize cryopreservation in the life sciences, with a focus on cells and tissues that currently cannot be maintained under medium and long-term storage conditions.


The VISION of CryoCrate is to be the premier supplier of cryopreservation solutions to the life science and clinical markets.


CryoCrate operates out of the Missouri Innovation Center in Columbia, MO, where we have access to offices, conference rooms, and University of Missouri laboratories and facilities for research and testing.